Navidea Biopharmaceuticals Profit Margin 2006-2019 | NAVB
Current and historical gross margin, operating margin and net profit margin for Navidea Biopharmaceuticals (NAVB) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Navidea Biopharmaceuticals net profit margin as of September 30, 2019 is -1509.18%.
|Navidea Biopharmaceuticals Annual Profit Margins
|Navidea Biopharmaceuticals Quarterly Profit Margins
||Medical Instruments Manufacturing
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio.